4//SEC Filing
Yocca Frank 4
Accession 0001104659-25-069702
CIK 0001720893other
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 8:27 PM ET
Size
5.2 KB
Accession
0001104659-25-069702
Insider Transaction Report
Form 4
Yocca Frank
Chief Scientific Officer
Transactions
- Award
Common Stock
2025-07-22+4,375→ 6,316 total
Footnotes (1)
- [F1]The Issuer previously granted the Reporting Person an award of restricted stock units that would vest based on the Issuer's satisfaction of certain performance objectives and subject to the Reporting Person's continued service with the Issuer through July 22, 2025 (the "PSUs"). On July 22, 2025, the Compensation Committee of the Issuer's Board of Directors determined that performance conditions with respect to 4,375 PSUs had been satisfied and 4,375 shares of common stock became issuable to the Reporting Person on July 22, 2025.
Documents
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
Related Parties
1- filerCIK 0001733272
Filing Metadata
- Form type
- 4
- Filed
- Jul 21, 8:00 PM ET
- Accepted
- Jul 22, 8:27 PM ET
- Size
- 5.2 KB